Omada Health
OMDA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | 38.3% | 37.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| % Margin | 60.6% | 57% | 48% |
| R&D Expenses | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 |
| % Margin | -25.7% | -53.8% | -81.1% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 |
| % Margin | -27.8% | -55% | -81.3% |
| EPS | -0.85 | -1.21 | -1.3 |
| % Growth | 29.8% | 6.9% | – |
| EPS Diluted | -0.85 | -1.21 | -1.3 |
| Weighted Avg Shares Out | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 |
| Supplemental Information | – | – | – |
| Interest Income | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 |
| % Margin | -22.3% | -47.5% | -71.7% |